MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.340
-0.070 (-4.96%)
Apr 21, 2026, 11:00 AM EDT - Market open
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $81.3 million as of April 21, 2026. Its market cap has increased by 72.82% in one year.
Market Cap
81.30M
Enterprise Value
74.16M
1-Year Change
72.82%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has increased from $51.10M to $81.30M, an increase of 59.10%. That is a compound annual growth rate of 13.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 85.55M | 46.12% |
| Dec 31, 2025 | 58.55M | 13.04% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gain Therapeutics | 89.55M |
| PolyPid | 89.50M |
| LeonaBio | 88.11M |
| TScan Therapeutics | 85.94M |
| Alterity Therapeutics | 85.80M |
| Seres Therapeutics | 85.70M |
| Filana Therapeutics | 84.54M |
| Champions Oncology | 84.36M |